|Bid||23.15 x 800|
|Ask||24.17 x 800|
|Day's Range||22.56 - 23.34|
|52 Week Range||10.02 - 28.77|
|Beta (5Y Monthly)||1.27|
|PE Ratio (TTM)||N/A|
|Earnings Date||Mar 04, 2024 - Mar 08, 2024|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||32.00|
Subscribe to Yahoo Finance Plus to view Fair Value for QTRX
Does Quanterix Corporation (QTRX) have what it takes to be a top stock pick for momentum investors? Let's find out.
The mean of analysts' price targets for Quanterix Corporation (QTRX) points to a 33.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
BILLERICA, Mass., November 13, 2023--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that President and Chief Executive Officer Masoud Toloue will speak in a fireside chat at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on Thursday, November 16, 2023 at 3:00 PM ET. To access the live webcast, please register here. A replay will be available following the conference on Quante